Quantum Biopharma Total Assets Growth & History (QNTM)
Quantum Biopharma's total assets was $11.2M for fiscal 2025.
View full Quantum Biopharma company overviewQuantum Biopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.2M | −$6.0M | −34.80% |
| 2024 | 2024-12-31 | $17.1M | −$355,604 | −2.03% |
| 2023 | 2023-12-31 | $17.5M | −$20.9M | −54.51% |
| 2022 | 2022-12-31 | $38.4M | −$24.6M | −38.99% |
| 2021 | 2021-12-31 | $63.0M | $21.0M | +50.03% |
| 2020 | 2020-12-31 | $42.0M | −$1.3M | −2.89% |
| 2019 | 2019-12-31 | $43.2M | — | — |
Quantum Biopharma quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.4M | −$905,146 | −5.92% |
| Q1 2026 | 2026-03-31 | $14.9M | $52,606 | +0.35% |
| Q4 2025 | 2025-12-31 | $11.2M | −$6.0M | −34.80% |
| Q3 2025 | 2025-09-30 | $14.2M | −$4.9M | −25.61% |
| Q2 2025 | 2025-06-30 | $15.3M | $50,082 | +0.33% |
| Q1 2025 | 2025-03-31 | $14.9M | — | — |
| Q4 2024 | 2024-12-31 | $17.1M | −$355,604 | −2.03% |
| Q3 2024 | 2024-09-30 | $19.0M | — | — |
| Q2 2024 | 2024-06-30 | $15.2M | — | — |
| Q4 2023 | 2023-12-31 | $17.5M | −$20.9M | −54.51% |
| Q4 2022 | 2022-12-31 | $38.4M | −$24.6M | −38.99% |
| Q4 2021 | 2021-12-31 | $63.0M | $21.0M | +50.03% |
| Q4 2020 | 2020-12-31 | $42.0M | −$1.3M | −2.89% |
| Q4 2019 | 2019-12-31 | $43.2M | — | — |
Quantum Biopharma total assets trends
Over the last five fiscal years, Quantum Biopharma's total assets decreased from $42.0M to $11.2M, a change of −$30.8M. The latest reported quarter, Q2 2026, shows $14.4M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quantum Biopharma source filings ↗